Select language:  
1800 620 420
Close menu

Optimal Care Pathways for myelodysplastic syndromes (MDS)

An illustration of two people embracing, with the text Optimal Care Pathways for patients and loved ones over the top.

Myelodysplastic syndromes (MDS, or myelodysplasia) are a group of blood cancers which all affect, to a greater or lesser extent, the production of normal blood cells in the bone marrow. MDS occurs as a result of a mutation (or change) in one or more of the genes that control blood cell development. This change or changes results in the abnormal growth of blood stem cells.

Disease-specific Guides to Best Cancer Care have been developed for the following diseases. The guides help people with cancer to understand the optimal cancer care they should be provided and support people to understand what might happen at each step of their cancer experience and consider what questions to ask.

Myelodysplastic syndromes (MDS)

Myelodysplastic syndromes

Relevant information that may be of interest for myelodysplastic syndromes (MDS) patients

myelodysplastic syndromes (MDS) information

Support groups

Join one of our regular support groups


Listen to one of our informative podcasts


Watch our recorded webinars